Item 2. Unregistered Sales of Equity Securities
Item 2. Unregistered Sales of Equity Securities and
Use of Proceeds
On
February
5,
2020,
our
board
of
directors
approved
the
replenishment
of
our
existing
share
repurchase
authorization
to
repurchase up to an aggregate of $100 million of common stock. The authorization
has no expiration date.
The table below presents information relating to purchases
of shares of our common stock
during the third quarter of fiscal 2025:
Table 22
(a)
(b)
(c)
(d)
Period
Total
number
of shares
purchased
Average price
paid per share
(US dollars)
Total
number of shares
purchased as part of publicly
announced plans or
programs
Maximum dollar value of
shares that may yet be
purchased under the plans
or programs
Jan 1, 2025 - Jan 31, 2025
-
-
-
100,000,000
Feb 1, 2025 - Feb 28, 2025
(1)
5,662
4.86
-
100,000,000
Mar 1, 2025 - Mar 31, 2025
-
-
-
100,000,000
Total
5,662
-
(1) Relates to the delivery of
5,662 shares of our common stock in
February 2025 to us by certain
of our employees to settle their
income tax liabilities. These shares do not reduce the repurchase authority
under the share repurchase program.
Other than as
reported in a
Current Report on
Form 8-K, we
did not
sell any
securities that
were not registered
under the Securities
Act during the third quarter of fiscal 2025.
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.